COCP
Cocrystal Pharma, Inc. - Common Stock (COCP)
$02
About Cocrystal Pharma, Inc. - Common Stock (COCP)
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.
Details
Daily high
$1.04
Daily low
$1.01
Price at open
$1.02
52 Week High
$3.26
52 Week Low
$0.90
Market cap
14.1M
Dividend yield
0.00%
Volume
19,300
Avg. volume
65,263
P/E ratio
-1.09
Cocrystal Pharma, Inc. - Common Stock News
Details
Daily high
$1.04
Daily low
$1.01
Price at open
$1.02
52 Week High
$3.26
52 Week Low
$0.90
Market cap
14.1M
Dividend yield
0.00%
Volume
19,300
Avg. volume
65,263
P/E ratio
-1.09